The obstructive sleep apnoea/hypopnoea syndrome - An overview

Athanasia Pataka, Renata L. Riha*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

In the last 30 years, there has been an explosion in facilities for the diagnosis and treatment of the obstructive sleep apnoea/hypopnoea syndrome (OSAHS) as well as a rapid advancement in the understanding of its consequences. In the general population, the prevalence of OSAHS is approximately 3-7% in adult men and 2-5% in adult women. OSAHS has been recognised as an independent risk factor for disorders such as hypertension, cardiovascular disease and sleepiness-related accidents. Currently, it is considered to be a systemic disease. This review provides a general overview of OSAHS: its epidemiology, pathophysiology, clinical features, diagnosis and treatment, as well as its consequences for public health. Crown

Original languageEnglish
Pages (from-to)111-117
Number of pages7
JournalRespiratory Medicine
Issue number3
Publication statusPublished - 29 Apr 2009

Keywords / Materials (for Non-textual outputs)

  • Consequences
  • Diagnosis
  • Obstructive sleep apnoea/hypopnoea syndrome
  • Review
  • Risk factors
  • Treatment


Dive into the research topics of 'The obstructive sleep apnoea/hypopnoea syndrome - An overview'. Together they form a unique fingerprint.

Cite this